ClinicalTrials.Veeva

Menu

Intensive TMS for Bipolar Depression

University of Pennsylvania logo

University of Pennsylvania

Status

Completed

Conditions

Treatment Resistant Depression
Bipolar Depression

Treatments

Device: Intensive intermittent theta-burst stimulation (iTBS)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The research study is being conducted to test whether using high dose spaced theta-burst rTMS (a form of transcranial magnetic stimulation) produces a significant reduction in depressive symptoms compared with sham. This project will recruit patients aged 18-70 with symptoms of bipolar depression who have failed (or not shown signs of improvement) after at least two prior treatments.

Full description

The research study is being conducted to test whether using high dose spaced theta-burst rTMS (a form of transcranial magnetic stimulation) produces a significant reduction in depressive symptoms compared with sham. This project will recruit patients aged 18-70 with symptoms of bipolar depression who have failed (or not shown signs of improvement) after at least two prior treatments. The null hypothesis is that there will be no difference in reductions in depressive symptoms by the end of a five-day treatment period. The alternative hypothesis is that, compared with sham, active TMS will result in a greater reduction in depressive symptoms by the end of the treatment period. Participants will be randomly assigned to active or sham conditions: 50% to active and 50% to sham.

Enrollment

34 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Bipolar depression (BP I and BP II) by Diagnostic and Statistical Manual 5 (DSM 5) criteria
  • Age 18-70
  • Right or left handed
  • All genders
  • Treatment resistant depression, as in they must have treatment resistant depression with 2 or more prior antidepressant trials that have failed to produce a response (> 50% reduction in symptoms) using ATHF criteria
  • Able to provide informed consent to participate in the study
  • Must be on a stable medication regimen, requiring at least one mood stabilizer
  • Depression severity as represented by scoring at least 20 on Montgomery-Asberg Depression Rating Scale (MADRS)

Exclusion criteria

  • No current substance abuse disorder for the past 6 months (previous substance abuse not exclusionary)
  • Any psychotic disorder or current active psychotic symptoms (personality disorders not exclusionary unless in the opinion of the referring psychiatrist it would jeopardize participation)
  • No dementia or other major neurological disorders
  • Not having depression as primary disorder
  • No major medical illness, for example metastatic cancer, end stage renal disease
  • Not able to verify contact information. Participants must be able to follow through with the study & must have verified contact information and at least one verified contact
  • Pregnancy. While there are no known risks to a fetus this is a new use of TMS, which has not been tested, thus pregnancy is exclusionary
  • Score on Young Mania Rating Scale (YMRS) greater than 12 (patients with mixed features have been shown not to respond well to TMS treatment)
  • Rapid cycling Bipolar illness (patients with > 4 mood episodes within the past year will be excluded, as they have a higher risk of switch to mania)
  • Any implants, conditions, or contraindications that would be deemed unsafe for TMS or MRI
  • Currently using benzodiazepines (such as lorazepam) with a dose >1 mg per day or equivalent.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

34 participants in 2 patient groups

Active Transcranial Magnetic Stimulation
Active Comparator group
Description:
Active Intensive iTBS involves intermittent theta-burst stimulation (iTBS), a patterned form of repetitive transcranial magnetic stimulation (rTMS) over the left dorsal lateral prefrontal cortex (L-DLPFC).
Treatment:
Device: Intensive intermittent theta-burst stimulation (iTBS)
Sham Transcranial Magnetic Stimulation
Sham Comparator group
Description:
Sham Intensive iTBS involves using the coil's electric stimulation functionality that allows for the delivery of a brief electric pulse to the scalp simultaneous to the TMS pulse, which mimics the scalp sensation from active stimulation.
Treatment:
Device: Intensive intermittent theta-burst stimulation (iTBS)

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems